van den Broek Richard 4
4 · Corvus Pharmaceuticals, Inc. · Filed Apr 9, 2025
Insider Transaction Report
Form 4
van den Broek Richard
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-04-08+30,000→ 30,000 totalExercise: $2.82Exp: 2035-04-08→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to one-third (1/3rd) of the shares subject to the option on each annual anniversary measured from April 8, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.